Bikson joins 2023 Bioelectronic Medicine Forum (April 4, 2023)

Prof. Marom Bikson will 2023 Bioelectronic Medicine Forum (April 4, 2023) held at New York Academy of Medicine, New York, NY (and Zoom). More program details

Download Pro. Bikson’s presentation on “Personalized medicine (Neuromodulation technology) has individually tuned dose. “. PDF

Tentative Agenda, All Times EDT

8:30-8:45

Welcome and Introductions

8:45-9:00

Overview of the Bioelectronic Medicine Industry

James Cavuoto, Editor, Neurotech Reports

BioElectRx Business Report Editor James Cavuoto presents an overview of the bioelectronic medicine industry, including key players, technological roots, and market projections.

9:00-9:30

Keynote Address

Helen Mayberg, M.D., Director, Center for Advanced Circuit Therapeutics, Icahn School of Medicine at Mount Sinai

One of the pioneers in the field of neuromodulation for psychiatric disorders discusses the interplay between pharmacological and device interventions in treating disease.

9:30-10:15

Investment in Bioelectronic Medicine

JoJo Platt, Senior Contributing Editor, Neurotech Reports, Moderator

Josh Schulman, Ph.D., Chief Science Officer, Joy Ventures

Amy Kruse, Ph.D., Chief Innovation Officer, Satori Capital

In this session, investment professionals active in the life sciences industry will offer their views on the investment climate for bioelectronic medicine.

10:15-10:45

Refreshment Break

10:45-11:30

Entrepreneur Panel I

James Cavuoto, Editor, Neurotech Reports, Moderator

Brad Schmidt, Ph.D., CEO, Panaxium

Sandro Ferrari, Ph.D., Director of Operations, WISE srl

Presentations from executives of emerging bioelectronic medicine firms.

11:30-12:00

Exploiting the Enteric Nervous System

James Cavuoto, Editor, Neurotech Reports, Moderator

Victor Pikov, Ph.D., CEO, Medipace Inc.

Jennifer French, Executive Director, Neurotech Network

The brain-gut connection not only opens the door to new bioelectronic medicine therapies for gastrointestinal disorders, it also offers a potential back door to the CNS. In this session, we'll explore potential new therapies and opportunities to collaborate with biopharma firms.

12:00-1:00

Luncheon

1:00-1:30

Luncheon Speaker

Will Pitkin, Senior Director of Business Development and Neuromodulation Strategy, Cirtec Medical

1:30-2:15

Biomarkers Close the Loop in Bioelectronic Medicine

Victor Pikov, Ph.D., Contributing Editor, Neurotech Reports, Moderator

Marom Bikson, Ph.D., Professor of Biomedical Engineering, City College of New York

Imanuel Lerman, M.D., Founder, InflammaSense

The ability to track neural activity offers bioelectronic medicine vendors several advantages. In this session, we'll look at examples of closed-loop neuromodulation and discuss new areas that stand to beneift.

2:15-3:00

Entrepreneur Panel II

James Cavuoto, Editor, Neurotech Reports, Moderator

Marc Powell, Ph.D., CEO, Reach Neuro Inc.

Karen Crow, CEO and Co-Founder, NeuroGeneces

Presentations from executives of emerging bioelectronic medicine firms.

3:00-3:30

Refreshment Break

3:30-4:15

Entrepreneur Panel III

James Cavuoto, Editor, Neurotech Reports, Moderator

Christine Aytug, Director of Business Development, Evren Technologies

Jacob Robinson, Ph.D., Co-Founder and CEO, Motif Neurotech

Presentations from executives of emerging bioelectronic medicine firms.

4:15-5:00

Who Foots the Bill? New Economic Models and Reimbursement Options

Jeremy Koff, Senior Consulting Editor, Neurotech Reports, Moderator

Renee Ryan, CEO, Cala Health

Mark Domyahn, Partner, J.D. Lymon Group

Bioelectronic medicine therapies occupy some new terrain when it comes to payment models and reimbursement strategies. In this session, we'll explore recent trends in device coverage and look at best practices for obtaining reimbursement.


5:00-6:30

Cocktail Reception

Marom Bikson